Thursday, June 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Regents of the University of California”

3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,494
Index total 30,257
Page 48 / 146

Quick answer

This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,494 results for “The Regents of the University of California” · 30,257 patents in full index Clear search

  1. US 10357217

    Method for positron emission tomography (PET) imaging analysis for classifying and diagnosing of neurological diseases

    The Regents of the University of California · Granted Jul 23, 2019 · Expires Jul 18, 2039

    granted

  2. US 10351878

    Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

    The Regents of the University of California · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted

  3. US 10351580

    Acene-based transmitter molecules for photon upconversion

    The Regents of the University of California · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted

  4. US 10350267

    Polypeptide-polymer conjugates and methods of use thereof

    The Regents of the University of California · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted

  5. US 10350249

    Reduction of milk glycans and their degradation products in the neonate gut

    The Regents of the University of California · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted

  6. US 10343981

    Modulators of the eIF2alpha pathway

    The Regents of the University of California · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  7. US 10343903

    Cationic polymer coated mesoporous silica nanoparticles and uses thereof

    The Regents of the University of California · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  8. US 10342882

    TCO conjugates and methods for delivery of therapeutic agents

    The Regents of the University of California · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  9. US 10342869

    Compositions comprising anti-CD38 antibodies and lenalidomide

    The Regents of the University of California · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  10. US 10344096

    Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis

    The Regents of the University of California · Granted Jul 9, 2019 · Expires Jul 4, 2039

    granted

  11. US 10337029

    Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

    The Regents of the University of California · Granted Jul 2, 2019 · Expires Jun 27, 2039

    granted

  12. US 10335491

    Catalytic delivery nanosubstrates (CDNS) for highly efficient delivery of biomolecules

    The Regents of the University of California · Granted Jul 2, 2019 · Expires Jun 27, 2039

    granted

  13. US 10335458

    Pharmaceutical compositions for treating or preventing bone conditions

    The Regents of the University of California · Granted Jul 2, 2019 · Expires Jun 27, 2039

    granted

  14. US 10329552

    Vaccine for livestock production systems

    The Regents of the University of California · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted

  15. US 10329356

    Fungal-specific metalloproteases and uses thereof

    The Regents of the University of California · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted

  16. US 10328160

    Hollow silica nanospheres and methods of making same

    The Regents of the University of California · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted

  17. US 10328161

    Luciferin derivatives from bicyclic reactants and aminothiol derivatives and methods of use thereof

    The Regents of the University of California · Granted Jun 25, 2019 · Expires Jun 20, 2039

    granted

  18. US 10314889

    Suppression of allergic lung inflammation and hyperreactivity

    The Regents of the University of California · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted

  19. US 10314885

    Oxytocin treatment to modify blood glucose and treat metabolic disease

    The Regents of the University of California · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted

  20. US 10314818

    Salinosporamides and methods of use thereof

    The Regents of the University of California · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted

  21. US 10308961

    Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

    The Regents of the University of California · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  22. US 10308638

    Selective alpha-7 nicotinic receptor agonists and methods for making and using them

    The Regents of the University of California · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  23. US 10308708

    Antibodies that neutralize botulinum neurotoxins

    The Regents of the University of California · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  24. US 10307428

    Therapeutic compositions for diabetic symmetrical polyneuropathy

    The Regents of the University of California · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.